Managing Clinical and Translational Research During COVID
Webinar | English | 1 Hr 20 Min
Image For Activity Cover
Credit Offered
No Credit Offered
This webinar utilizes a team approach to explore challenges and provide best practices for conducting clinical and translational research during the COVID pandemic. A multidisciplinary faculty composed of physician researchers, a nurse clinical coordinator, a patient advocate and a pharmaceutical company representative will discuss the following topics: review and implementation of federal and international COVID guidelines, best practices for keeping clinical trials accessible to patients and labs open, best practices for study coordination and team wellness, and the effect of COVID on patients.
This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.
Upon completion of this activity, the participants should be able to: 
  • Review the federal and international COVID guidelines.
  • Understand the best practices for keeping clinical trials accessible to patients and labs open.
  • Understand best practices for study coordination and team wellness.
  • Understand the effect of COVID on patients.
  • Joachim Aerts, MD, PhD
  • Kirsten Black, PhD, MPH
  • Amy C. Moore, PhD 
  • Jyoti Patel, MD, FASCO
  • M. Catherine Pietanza, MD
  • Christian Rolfo, MD, PhD, MBA, Dr.hc.
  • Buerkley Rose, MSN, RN, HPE 
  • Aubrey Shoe, MA
  • Antoinette Wozniak, MD, FACP, FASCO

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email:
Powered By